中华实验眼科杂志
中華實驗眼科雜誌
중화실험안과잡지
CHINESE JOURNAL OF EXPERIMENTAL OPHTHALMOLOGY
2014年
1期
94-96
,共3页
糖尿病视网膜病变%非可控性炎症%炎性因子%高糖
糖尿病視網膜病變%非可控性炎癥%炎性因子%高糖
당뇨병시망막병변%비가공성염증%염성인자%고당
Diabetic retinopathy%Nonresolving inflammation%Inflammatary factor%Hyperglycemia
非可控性炎症在多种疾病的发生发展中起到重要作用.糖尿病视网膜病变(DR)是一种低度慢性炎症性疾病,确切地说可能是一种非可控性炎症.DR中的中性粒细胞不能及时凋亡或被清除、不同表型的巨噬细胞同时存在、周细胞功能减弱、Th1细胞反应降低等细胞因素致DR炎症不易缓解.与此同时,抗炎型可溶性因子含量的降低,如白细胞介素-10(IL-10)、转化生长因子-β(TGF-β)、一氧化氮(NO)、环氧化二十碳三烯甘油酸(EETs)、脂氧素等进一步使炎症持续.此外高糖条件下产生的脂质代谢产物、糖基化终末产物、活性氧中间产物(ROI)等持续存在的刺激因素均可导致炎症不能缓解.对DR炎症发病机制的深入理解有助于探索新的治疗途径,延缓其发生发展.
非可控性炎癥在多種疾病的髮生髮展中起到重要作用.糖尿病視網膜病變(DR)是一種低度慢性炎癥性疾病,確切地說可能是一種非可控性炎癥.DR中的中性粒細胞不能及時凋亡或被清除、不同錶型的巨噬細胞同時存在、週細胞功能減弱、Th1細胞反應降低等細胞因素緻DR炎癥不易緩解.與此同時,抗炎型可溶性因子含量的降低,如白細胞介素-10(IL-10)、轉化生長因子-β(TGF-β)、一氧化氮(NO)、環氧化二十碳三烯甘油痠(EETs)、脂氧素等進一步使炎癥持續.此外高糖條件下產生的脂質代謝產物、糖基化終末產物、活性氧中間產物(ROI)等持續存在的刺激因素均可導緻炎癥不能緩解.對DR炎癥髮病機製的深入理解有助于探索新的治療途徑,延緩其髮生髮展.
비가공성염증재다충질병적발생발전중기도중요작용.당뇨병시망막병변(DR)시일충저도만성염증성질병,학절지설가능시일충비가공성염증.DR중적중성립세포불능급시조망혹피청제、불동표형적거서세포동시존재、주세포공능감약、Th1세포반응강저등세포인소치DR염증불역완해.여차동시,항염형가용성인자함량적강저,여백세포개소-10(IL-10)、전화생장인자-β(TGF-β)、일양화담(NO)、배양화이십탄삼희감유산(EETs)、지양소등진일보사염증지속.차외고당조건하산생적지질대사산물、당기화종말산물、활성양중간산물(ROI)등지속존재적자격인소균가도치염증불능완해.대DR염증발병궤제적심입리해유조우탐색신적치료도경,연완기발생발전.
Nonresolving inflammation plays an important role in the onset and development of various diseases.Diabetic retinopathy (DR) is a low-degree chronic inflammatory process,and actually it would be a nonresolving inflammatory disease.Failure of neutrophils apoptosis in time,converting failure of macrophages from a pro-inflammatory to anti-inflammatory phenotype,dysfunction of pericytes and poor activation of Thl cells are all contributed to inflammatory prolong.Meanwhile the low concentration of anti-inflammatory soluble factors such as interleukin-10 (IL-10),transforming growth factor-β (TGF-β),nitric oxide (NO),epoxyeicosatrienoic acids (EETs)and lipoxins in serum or ocular specimen are also benefit to failure of inflammatory resolution.In addition,persistent stimulation such as lipid products,advanced glycation end products(AGEs) and reactive oxygen intermediate (ROI)deteriorate the inflammation persistently.More understanding of DR pathogenesis greatly complicates the development of anti-inflammatory therapy.